SALT LAKE CITY, March 09, 2016 -- Park City Group’s ReposiTrak® Inc., the leading provider of Compliance Management and Track & Trace solutions for food, pharma and dietary supplement safety, announces that Minnesota-based Coborn’s Inc. has chosen ReposiTrak to manage regulatory and business documentation compliance within their supply chain. Recognized in 2011 as Grocery Headquarters magazine’s “Independent Retailer of the Year”, Coborn’s operates a chain of 41 Coborn’s, Cash Wise Foods and Save-A-Lot grocery stores in the upper Midwest, along with convenience, liquor, video stores and pharmacies. Founded in 1921 by Chester Coborn, Coborn’s is now managed by a fourth generation family member – Chris Coborn.
“For over 95 years, shoppers have trusted our stores to provide them with safe, quality food,” said Chris Coborn, President and CEO of Coborn’s. “With FSMA finalizing in less than six months, we were looking for an automated system that would enable us to better manage our growing list of compliance documentation and help protect Coborn’s brand equity.”
“Coborn’s is one of many retailers leveraging ReposiTrak to reduce brand, regulatory and financial risk in their supply chain,” said Randall K. Fields, Chairman and CEO of Park City Group. “Their commitment to food safety and supply chain transparency makes us proud to have them utilize our system.”
ReposiTrak, a wholly owned subsidiary of Park City Group (NASDAQ:PCYG) helps manage regulatory, financial and brand risk associated with issues of safety in the global food, pharma and dietary supply chains. Powered by Park City Group’s technology, the platform consists of two systems: Compliance Management, which not only receives, stores and shares documentation, but also manages compliance through dashboards and alerts for missing or expired documents; and Track & Trace, which quickly identifies product ingredients and their supply chain path in the unfortunate event of a product recall. It can reduce the risk in the supply chain by identifying backward chaining sources and forward chaining recipients of products in near real time.
About ReposiTrak
ReposiTrak is a wholly-owned subsidiary of Park City Group (NASDAQ:PCYG) and was co-founded with Leavitt Partners. ReposiTrak® provides food retailers and suppliers with a robust solution to help them protect their brands and remain in compliance with the rapidly evolving regulations in the Food Safety Modernization Act. Additionally, ReposiTrak enables traceability as products and their ingredients move between trading partners. More information is available at www.repositrak.com.
About Park City Group
Park City Group (PCYG) is a Software-as-a-Service (“SaaS”) provider that brings unique visibility to the consumer goods supply chain, delivering actionable information to ensure products are available when and where consumers demand them, helping retailers and suppliers to ‘Sell More, Stock Less, and See Everything’. Park City Group’s technology also assists all participants in the food and drug supply chains to comply with food and drug safety regulations through the Company’s ReposiTrak subsidiary. More information is available at www.parkcitygroup.com.
Media Contact Ronald Margulis RAM Communications +1 908.272.3930 [email protected]


Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 



